The 2021 WHO Classification of Tumors of the Central Nervous System: a summary
David N. Louis, Arie Perry, Pieter Wesseling, Daniel Jay Brat, Ian A. Cree, Dominique Figarella‐Branger, Cynthia E Hawkins, Ho‐Keung Ng, Stefan Michael Pfister, Guido Reifenberger, Riccardo Soffietti, Andreas von Deimling, David W. Ellison
Neuro-Oncology · 2021 · 13,127 citationsOpen access
No retraction on record in OpenAlex.Check Crossref now
Cite this paper
Louis, D. N., Perry, A., Wesseling, P., Brat, D. J., Cree, I. A., Figarella‐Branger, D., Hawkins, C. E., Ng, H., Pfister, S. M., Reifenberger, G., Soffietti, R., Deimling, A. von, & Ellison, D. W. (2021). The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro-Oncology, 23(8), 1231–1251. https://doi.org/10.1093/neuonc/noab106
In text: (Louis et al., 2021)
Ask a question about this research
One question, free, no account. Anchorcite finds the papers, checks each against Crossref and links every sentence of the answer to the passage it comes from.
Abstract
The fifth edition of the WHO Classification of Tumors of the Central Nervous System (CNS), published in 2021, is the sixth version of the international standard for the classification of brain and spinal cord tumors. Building on the 2016 updated fourth edition and the work of the Consortium to Inform Molecular and Practical Approaches to CNS Tumor Taxonomy, the 2021 fifth edition introduces major changes that advance the role of molecular diagnostics in CNS tumor classification. At the same time, it remains wedded to other established approaches to tumor diagnosis such as histology and immunohistochemistry. In doing so, the fifth edition establishes some different approaches to both CNS tumor nomenclature and grading and it emphasizes the importance of integrated diagnoses and layered reports. New tumor types and subtypes are introduced, some based on novel diagnostic technologies such as DNA methylome profiling. The present review summarizes the major general changes in the 2021 fifth edition classification and the specific changes in each taxonomic category. It is hoped that this summary provides an overview to facilitate more in-depth exploration of the entire fifth edition of the WHO Classification of Tumors of the Central Nervous System.
Related papers
- The 2007 WHO Classification of Tumours of the Central Nervous System2007
- CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2006-20102013
- Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF12010
- MGMT Gene Silencing and Benefit from Temozolomide in Glioblastoma2005
- The Multimodal Brain Tumor Image Segmentation Benchmark (BRATS)2014
Metadata from OpenAlex (CC0). Citations are generated from the published record.